
Xylanase is a hydrolase enzyme that degrades xylan, a major component of hemicellulose found in plant biomass. 21 soil samples were collected from Lahore District. 16 fungal isolates were isolated and screened for xylanase production. Six fungal isolates showed positive xylanolytic activity, ZGCL22, ZGCL49, ZGCL18, ZGCL44, ZGCL51 and ZGCL12. Wheat bran was the most effective agricultural substrate. Five isolates had optimal xylanase production when fermented at 30 oC and pH 5.0. ZGCL44 showed maximum xylanase production at pH 9.0. Enzyme analysis conditions were optimal at 50 °C, 30 minutes and 1% beechwood xylan. These conditions do not represent optimal temperatures for fungal growth and enzyme production. The UV treated isolates of ZGCL22, ZGCL49 and ZGCL12 had xylanolytic activity after 5 minutes of exposure of 0.97, 1.01 and 1.18 IU/mL respectively. This method used ITS primers and thus should be verified for correct molecular identification and the xylanase encoding gene
Wheat dough is often kneaded in advance and held before use in south Asian households, yet little is known about how holding conditions affect its microbial load. This study isolated, enumerated and characterized bacteria and fungi from homemade kneaded wheat dough held for 24 h under refrigeration (4 °c; S1) or at room temperature (S2), and from a visibly contaminated homemade pickle (S3). ten-fold serial dilutions were spread on nutrient agar (NA; 10⁻⁵ and 10⁻⁶) and potato dextrose agar (PDA; 10⁻⁴ and 10⁻⁵), colonies were counted, pure bacterial cultures were obtained by streak plating, and four isolates (b1–b4) were described by colony morphology and gram reaction. only the 10⁻⁶ NA dilution gave countable plates for all samples. from these plates, the estimated bacterial load was highest in room-temperature dough (1.5 × 10⁹ CFU g⁻¹; 9.18 log CFU g⁻¹), lower in refrigerated dough (8.5 × 10⁸ CFU g⁻¹; 8.93 log CFU g⁻¹) and lowest in the pickle (4.8 × 10⁸ CFU g⁻¹; 8.68 log CFU g⁻¹). the pickle yielded the highest fungal count (72 colonies at 10⁻⁴; about 7.2 × 10⁶ CFU g⁻¹), and large, dark, spreading molds were evident on PDA from room-temperature dough. Three of the four bacterial isolates were gram-positive, and one was a gram-negative rod. fungal colonies were morphologically consistent with Aspergillus species (A. candidus- and A. niger-like). These identifications are presumptive because no molecular or other confirmatory tests were performed. because several Aspergillus species are potential mycotoxin producers, these observations have food-safety relevance, although mycotoxins were not measured in this study. Under the conditions examined, refrigeration was associated with a lower estimated bacterial load in kneaded dough; the study also illustrates a simple, low-cost culture-based workflow for teaching and screening laboratories and identifies the replication and confirmatory identification needed in future work.
Fusarium solani and Curvularia spp., are economically destructive phytopathogens affecting major crops across Pakistan, yet indigenous biocontrol agents with confirmed broad-spectrum efficacy against both remain undocumented from Sindh province. This study evaluated the antagonistic potential of 31 rhizospheric Bacillus isolates recovered from cotton and sugarcane fields of Kot Diji, District Khairpur, Sindh, against both target pathogens. Isolates were characterized through morphological, biochemical, and 16S rRNA gene sequencing approaches. Primary dual-culture screening identified seven antagonistic isolates; among these, S1C9 produced the greatest inhibition zone against F. solani (11.7 mm), while S3C9 achieved the maximum suppression of Curvularia spp. (15.3 mm). Isolate S6C8 demonstrated consistent broad-spectrum antagonism against both pathogens across primary and secondary screening rounds, recording inhibition zones of 8.7 mm and 11.3 mm against F. solani and Curvularia spp., respectively. Agar well diffusion assays using cell-free culture supernatants confirmed that diffusible metabolites are the principal mediators of antifungal activity; however, the comparatively reduced inhibition observed relative to dual-culture assays indicates that direct bacterial-fungal contact contributes supplementary inhibitory mechanisms. In secondary screening, isolates S3C8 and S3C9 produced the highest inhibition of F. solani (12.7 mm), while S1C9 recorded the greatest suppression of Curvularia spp. (9.0 mm). Photographic documentation provided visual confirmation of mycelial suppression within inhibition zones. Molecular identification confirmed isolate S6C8 as Bacillus aerius (GenBank: KY973966.1), constituting the first verified record of this species from Pakistani rhizosphere soil with demonstrated antifungal activity. These findings identify native rhizospheric Bacillus strains, particularly the multi-target isolate S6C8, as promising environmentally sustainable biocontrol candidates warranting further evaluation under field conditions.
Anabolic-androgenic steroids (AAS) comprise testosterone and its synthetic derivatives. They are widely used non-medically by athletes, recreational bodybuilders and gymnasium trainees to enhance muscle mass and physical performance, despite well-documented, multi-system adverse effects and, as reported in the literature, infectious risks that relate mainly to their injection. To review the pharmacology and mechanism of action of AAS, the clinical, toxic and microbiological effects reported in the literature, and the patterns of non-medical AAS use among trainees in gymnasiums, with particular reference to published studies from Iraq and the Middle East. A narrative, non-systematic review of the literature on AAS pharmacology, adverse effects, microbiological aspects and patterns of use, identified through PubMed/MEDLINE and Google Scholar, was undertaken. AAS act principally through binding to the androgen receptor, increasing muscle protein synthesis and, as has been proposed, limiting protein breakdown, thereby promoting muscle hypertrophy and recovery. The same supraphysiological androgen exposure underlies a broad range of dose- and duration-dependent adverse effects across most organ systems. Some of these improve after cessation, whereas others, including prolonged hypogonadism in men and several virilising effects in women, may persist. With regard to microbiological aspects, the established risks are injection-site bacterial infection and, where injecting equipment is shared, blood-borne virus transmission, together with acne, in which Cutibacterium acnes is one of several contributing factors. By contrast, androgen-mediated immune modulation and interaction with the gut microbiota rest largely on experimental evidence and remain hypotheses in AAS users. Published surveys of gymnasium users in Iraq report AAS use in about one-quarter to nearly one-half of participants (26.3% in Erbil and 44.8% in Baghdad), with trainers and coaches as the commonest source of recommendation and combined oral and injectable use in more than one-third of users. AAS possess genuine anabolic efficacy but carry substantial multi-organ toxicity and, when injected, infectious risk. In Iraq and the wider region, AAS use among gymnasium trainees appears to be common and is guided mainly by informal, non-medical sources of advice, while data on injection practices and infection are lacking. Structured education and monitoring in gymnasium settings deserve formal evaluation.
Gaucher disease (GD) is the most prevalent LSD, and skeletal disease is one of the most disabling and difficult to treat forms of the disease. This narrative review aims to assess the potential of total serum vitamin D [TSVD] (25 hydroxyvitamin D [25(OH)D]) as a biomarker for the diagnosis and monitoring of skeletal disease in GD. English-language data from PubMed, Scopus and Google Scholar databases were analyzed and searched for evidence using vitamin D, GD, bone disease, enzyme replacement therapy (ERT) and the terms relevant to biomarkers. Additionally, data from an unpublished case-control study were included in the review, consisting of 67 Iraqi children with GD, and 20 healthy children. The evidence suggests a high prevalence of vitamin D deficiency in GD patients, both geographically and potentially with lower BMD in adults with GD1. Total vitamin D, in the unpublished pediatric cohort, showed good discrimination of children with GD at initial presentation with the area under the receiver operating characteristic curve (AUC) of 0.90–1.00. After more than one year of ERT, however, vitamin D levels were still decreased compared to healthy controls. In addition, it was not very effective at distinguishing the different treatment-duration groups (AUC 0.52–0.68), meaning that it could not be used effectively for monitoring treatment response in short- to medium-term treatment. Overall, there is no existing evidence to support vitamin D as a standalone biomarker of skeletal response to ERT or substrate reduction therapy (SRT). The clinical relevance must be related to other direct skeletal evaluations and known markers like chitotriosidase. Nevertheless, vitamin D status should be measured at diagnosis and at regular intervals during follow up and corrected if deficiency is found; this is supportive care. Other prospective studies involving larger populations, the use of a standardized measurement of vitamin D, and validated skeletal endpoints are required to establish its utility for monitoring GD.